Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.2330
-0.0050 (-2.10%)
At close: Mar 13, 2026, 4:00 PM EDT
0.2379
+0.0048 (2.08%)
After-hours: Mar 13, 2026, 7:59 PM EDT
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $6.31 million as of March 13, 2026. Its market cap has decreased by -92.05% in one year.
Market Cap
6.31M
Enterprise Value
7.02M
1-Year Change
-92.05%
Ranking
Category
Stock Price
$0.23
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $6.31M, a decrease of -98.18%. That is a compound annual growth rate of -56.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 10.46M | -36.66% |
| Dec 31, 2025 | 16.51M | -79.39% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | 346.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dogwood Therapeutics | 7.02M |
| PharmaCyte Biotech | 6.99M |
| Evogene | 6.95M |
| Mustang Bio | 6.88M |
| Processa Pharmaceuticals | 6.68M |
| Moleculin Biotech | 6.53M |
| Xenetic Biosciences | 6.43M |
| Immuron | 6.39M |